318 related articles for article (PubMed ID: 23312374)
1. Modeling cognitive dysfunction in neurofibromatosis-1.
Diggs-Andrews KA; Gutmann DH
Trends Neurosci; 2013 Apr; 36(4):237-47. PubMed ID: 23312374
[TBL] [Abstract][Full Text] [Related]
2. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.
Omrani A; van der Vaart T; Mientjes E; van Woerden GM; Hojjati MR; Li KW; Gutmann DH; Levelt CN; Smit AB; Silva AJ; Kushner SA; Elgersma Y
Mol Psychiatry; 2015 Nov; 20(11):1311-21. PubMed ID: 25917366
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms.
Molosh AI; Shekhar A
Prog Brain Res; 2018; 241():37-62. PubMed ID: 30447756
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 1: modeling CNS dysfunction.
Gutmann DH; Parada LF; Silva AJ; Ratner N
J Neurosci; 2012 Oct; 32(41):14087-93. PubMed ID: 23055477
[TBL] [Abstract][Full Text] [Related]
5. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.
Brown JA; Emnett RJ; White CR; Yuede CM; Conyers SB; O'Malley KL; Wozniak DF; Gutmann DH
Hum Mol Genet; 2010 Nov; 19(22):4515-28. PubMed ID: 20826448
[TBL] [Abstract][Full Text] [Related]
6. Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.
Diggs-Andrews KA; Tokuda K; Izumi Y; Zorumski CF; Wozniak DF; Gutmann DH
Ann Neurol; 2013 Feb; 73(2):309-15. PubMed ID: 23225063
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cAMP and ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1.
Wolman MA; de Groh ED; McBride SM; Jongens TA; Granato M; Epstein JA
Cell Rep; 2014 Sep; 8(5):1265-70. PubMed ID: 25176649
[TBL] [Abstract][Full Text] [Related]
9. Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.
Donarum EA; Halperin RF; Stephan DA; Narayanan V
BMC Neurosci; 2006 Mar; 7():22. PubMed ID: 16524466
[TBL] [Abstract][Full Text] [Related]
10. Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level.
Hachon C; Iannuzzi S; Chaix Y
Brain Dev; 2011 Jan; 33(1):52-61. PubMed ID: 20106617
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 1.
North K
Am J Med Genet; 2000; 97(2):119-27. PubMed ID: 11180219
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular mechanisms of learning disabilities: a focus on NF1.
Shilyansky C; Lee YS; Silva AJ
Annu Rev Neurosci; 2010; 33():221-43. PubMed ID: 20345245
[TBL] [Abstract][Full Text] [Related]
13. Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.
Apostolova I; Niedzielska D; Derlin T; Koziolek EJ; Amthauer H; Salmen B; Pahnke J; Brenner W; Mautner VF; Buchert R
J Cereb Blood Flow Metab; 2015 Aug; 35(8):1304-12. PubMed ID: 25785829
[TBL] [Abstract][Full Text] [Related]
14. [Learning disorders in neurofibromatosis type 1].
Garcia-Penas JJ
Rev Neurol; 2017 Feb; 64(s01):S59-S63. PubMed ID: 28256688
[TBL] [Abstract][Full Text] [Related]
15. Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity.
Brown JA; Gianino SM; Gutmann DH
J Neurosci; 2010 Apr; 30(16):5579-89. PubMed ID: 20410111
[TBL] [Abstract][Full Text] [Related]
16. The systems biology of neurofibromatosis type 1--critical roles for microRNA.
Lee MJ; Cho JH; Galas DJ; Wang K
Exp Neurol; 2012 Jun; 235(2):464-8. PubMed ID: 22075182
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.
Warrington NM; Gianino SM; Jackson E; Goldhoff P; Garbow JR; Piwnica-Worms D; Gutmann DH; Rubin JB
Cancer Res; 2010 Jul; 70(14):5717-27. PubMed ID: 20551058
[TBL] [Abstract][Full Text] [Related]
18. Genetic and functional studies implicate synaptic overgrowth and ring gland cAMP/PKA signaling defects in the Drosophila melanogaster neurofibromatosis-1 growth deficiency.
Walker JA; Gouzi JY; Long JB; Huang S; Maher RC; Xia H; Khalil K; Ray A; Van Vactor D; Bernards R; Bernards A
PLoS Genet; 2013 Nov; 9(11):e1003958. PubMed ID: 24278035
[TBL] [Abstract][Full Text] [Related]
19. Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials.
Payne JM; Barton B; Shores EA; North KN
J Neurol; 2013 Jan; 260(1):214-20. PubMed ID: 22875098
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]